Nayak S K, Kakati S, Harvey S R, Malone C C, Cornforth A N, Dillman R O
Patty and George Hoag Cancer Center, Cell Biology Laboratory, Newport Beach, California 92658, USA.
In Vitro Cell Dev Biol Anim. 2000 Mar;36(3):188-93. doi: 10.1290/1071-2690(2000)036<0188:COCCLE>2.0.CO;2.
Cell lines are valuable resources for the study of the malignancy and potential therapy of human breast cancer. A major problem with adapting fresh breast tumor specimens to grow in vitro is contamination by fibroblasts. Previously, we have reported a technique to overcome this problem (Nayak, S. K; Dillman, R. O. Clin. Biotechnol. 3:237-242; 1991). We have recently established two new breast cancer cell lines, HH315 and HH375, that were derived from abdominal and supraclavicular lymph node metastases from two patients. They were characterized by (1) growth kinetics; (2) staining with monoclonal antibodies (MoAbs) to cytokeratin-19, epithelial membrane antigen (EMA), anticarcinoembryonic antigen (CEA), breast cancer antigen 1 (BRST-1), breast cancer antigen 2 (BRST-2), Her2/neu, and p53; (3) expression of domains of urinary plasminogen activator (uPA), neural cell adhesion molecule (NCAM), and haptoglobin (Hp) (Harvey et al., 1997); and (4) karyotypic analysis. Growth kinetic studies showed that doubling times for both lines ranged from 48 to 96 h. These two cell lines were found to have characteristics of the metastatic breast cancer cells. Both lines stained positive with MoAbs to cytokeratin-19 and EMA, thus confirming their epithelial origin. They also strongly reacted with the pan-breast carcinoma MoAbs BRST-1 and BRST-2, and carcinoembryonic CEA MoAb. Both cell lines overexpressed the oncogene proteins Her2/neu and p53. The tumor cells were negative for estrogen and progesterone receptors. HH315 cells were poorly differentiated, whereas the HH375 cells exhibited adenocarcinoma morphology. Both cell lines showed intense cell surface and some cytoplasmic staining for uPA, NCAM, and Hp domains, which is a characteristic of malignant neoplasms (Harvey et al., 1997). The HH375 cell line showed two cell types, of which 60% were hyperdiploids with 60-70 chromosomes and 5-10 marker chromosomes. The remaining cells were polyploid with more than 200 chromosomes. Cell line HH315 consisted of only a polyploid population. These cell lines may be useful in breast cancer research.
细胞系是研究人类乳腺癌恶性肿瘤及潜在治疗方法的宝贵资源。将新鲜乳腺肿瘤标本进行体外培养的一个主要问题是受到成纤维细胞的污染。此前,我们曾报道过一种克服该问题的技术(纳亚克,S.K;迪尔曼,R.O.《临床生物技术》3:237 - 242;1991)。我们最近建立了两个新的乳腺癌细胞系,HH315和HH375,它们分别来源于两名患者的腹部和锁骨上淋巴结转移灶。对它们进行了如下特征分析:(1)生长动力学;(2)用针对细胞角蛋白 - 19、上皮膜抗原(EMA)、癌胚抗原(CEA)、乳腺癌抗原1(BRST - 1)、乳腺癌抗原2(BRST - 2)、Her2/neu和p53的单克隆抗体(MoAbs)进行染色;(3)尿激酶型纤溶酶原激活剂(uPA)、神经细胞黏附分子(NCAM)和触珠蛋白(Hp)结构域的表达(哈维等人,1997);(4)核型分析。生长动力学研究表明,这两个细胞系的倍增时间在48至96小时之间。发现这两个细胞系具有转移性乳腺癌细胞的特征。两个细胞系用针对细胞角蛋白 - 19和EMA的MoAbs染色均呈阳性,从而证实了它们的上皮来源。它们还与泛乳腺癌MoAbs BRST - 1和BRST - 2以及癌胚CEA MoAb发生强烈反应。两个细胞系均过度表达癌基因蛋白Her2/neu和p53。肿瘤细胞的雌激素和孕激素受体均为阴性。HH315细胞分化程度低,而HH375细胞表现出腺癌形态。两个细胞系的uPA、NCAM和Hp结构域在细胞表面和部分细胞质中均呈现强烈染色,这是恶性肿瘤的一个特征(哈维等人,1997)。HH375细胞系显示出两种细胞类型,其中60%为超二倍体,有60 - 70条染色体和5 - 10条标记染色体。其余细胞为多倍体,染色体数超过200条。细胞系HH315仅由多倍体细胞群体组成。这些细胞系可能在乳腺癌研究中有用。